Ibrutinib for relapsed refractory hairy cell leukemia variant

被引：38

作者：

Bohn, Jan-Paul ^{[1
]}

Wanner, David ^{[1
]}

Steurer, Michael ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria

来源：

LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 05期

关键词：

BRUTONS TYROSINE KINASE; DIAGNOSIS;

D O I：

10.1080/10428194.2016.1239262

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1224 / 1226

页数：3

共 12 条

[1] VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy [J].

Arons, Evgeny ;

Suntum, Tara ;

Stetler-Stevenson, Maryalice ;

Kreitman, Robert J. .

BLOOD, 2009, 114 (21) :4687-4695

[2] Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior [J].

Forconi, Francesco ;

Sozzi, Elisa ;

Cencini, Emanuele ;

Zaja, Francesco ;

Intermesoli, Tamara ;

Stelitano, Caterina ;

Rigacci, Luigi ;

Gherlinzoni, Filippo ;

Cantaffa, Renato ;

Baraldi, Anna ;

Gallamini, Andrea ;

Zaccaria, Alfonso ;

Pulsoni, Alessandro ;

Gobbi, Marco ;

Tassi, Maristella ;

Raspadori, Donatella ;

Leoncini, Lorenzo ;

Rinaldi, Andrea ;

Sabattini, Elena ;

Bertoni, Francesco ;

Pileri, Stefano A. ;

Lauria, Francesco .

BLOOD, 2009, 114 (21) :4696-4702

[3] Targeting Bruton's tyrosine kinase in B cell malignancies [J].

Hendriks, Rudi W. ;

Yuvaraj, Saravanan ;

Kil, Laurens P. .

NATURE REVIEWS CANCER, 2014, 14 (04) :219-232

[4] High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia [J].

Hockley, S. L. ;

Morgan, G. J. ;

Leone, P. E. ;

Walker, B. A. ;

Morilla, A. ;

Else, M. ;

Wotherspoon, A. ;

Dearden, C. ;

Catovsky, D. ;

Gonzalez, D. ;

Matutes, E. .

LEUKEMIA, 2011, 25 (07) :1189-1192

[5] The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma [J].

Hockley, Sarah L. ;

Else, Monica ;

Morilla, Alison ;

Wotherspoon, Andrew ;

Dearden, Claire ;

Catovsky, Daniel ;

Gonzalez, David ;

Matutes, Estella .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (03) :347-354

[6] Preliminary safety and efficacy of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib (IBR) in patients (pts) with hairy cell leukemia (HCL). [J].

Jones, Jeffrey Alan ;

Andritsos, Leslie A. ;

Lucas, David M. ;

Lozanski, Gerard ;

Hutchinson, Terri ;

Sexton, Jennifer L. ;

Harris, Pamela Jo ;

Grever, Michael R. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[7] Immunophenotyping and differential diagnosis of hairy cell leukemia [J].

Matutes, Estella .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 20 (05) :1051-+

[8] Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro [J].

Robak, T. ;

Matutes, E. ;

Catovsky, D. ;

Zinzani, P. L. ;

Buske, C. ;

Comm, E. S. M. O. Guidelines .

ANNALS OF ONCOLOGY, 2015, 26 :V100-V107

[9] BRAF Mutations in Hairy-Cell Leukemia [J].

Tiacci, Enrico ;

Trifonov, Vladimir ;

Schiavoni, Gianluca ;

Holmes, Antony ;

Kern, Wolfgang ;

Martelli, Maria Paola ;

Pucciarini, Alessandra ;

Bigerna, Barbara ;

Pacini, Roberta ;

Wells, Victoria A. ;

Sportoletti, Paolo ;

Pettirossi, Valentina ;

Mannucci, Roberta ;

Elliott, Oliver ;

Liso, Arcangelo ;

Ambrosetti, Achille ;

Pulsoni, Alessandro ;

Forconi, Francesco ;

Trentin, Livio ;

Semenzato, Gianpietro ;

Inghirami, Giorgio ;

Capponi, Monia ;

Di Raimondo, Francesco ;

Patti, Caterina ;

Arcaini, Luca ;

Musto, Pellegrino ;

Pileri, Stefano ;

Haferlach, Claudia ;

Schnittger, Susanne ;

Pizzolo, Giovanni ;

Foa, Robin ;

Farinelli, Laurent ;

Haferlach, Torsten ;

Pasqualucci, Laura ;

Rabadan, Raul ;

Falini, Brunangelo .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24) :2305-2315

[10]

Vardiman JW., 2008, WHO CLASSIFICATION T

← 1 2 →